News Archive
Professor Terry Testifies Before Senate Committee on Opioid Misuse
05/23/2018
U.S. Senator Joe Donnelly announced that Indiana University Professor Nicolas P. Terry will testify on Wednesday, May 23 at 2:00 p.m. before the U.S. Senate Special Committee on Aging during a hearing entitled, “Preventing and Treating Opioid Misuse Among Older Americans.” Terry is speaking before the committee after Donnelly was instrumental in facilitating IU’s participation in the hearing, following the university’s new policy report on addressing the opioid epidemic.
Donnelly said, “I am pleased that Professor Terry will be coming before the Senate Special Committee on Aging to discuss opioid abuse among older Americans, and Indiana University’s new research and findings about ways to respond to this devastating epidemic. I believe it will take all of us continuing to work together to effectively confront the opioid crisis, and I look forward to Professor Terry’s testimony and Indiana University’s continued partnership in this effort.”
Terry said, “The opioid addictions crisis is a wicked problem that affects people of all ages across the United States. Through our Responding to the Addictions Crisis grand challenges program, Indiana University is committed to creating actionable, collaborative solutions to this crisis in partnership with those who have shown such commitment to this issue. I am particularly pleased to have this opportunity to discuss our team’s research and recommendations with the Senate Special Committee on Aging. Looking at the opioids crisis through an aging lens emphasizes our findings that we need workable care coordination and wrap-around services to make measurable improvements in people’s lives.”
Professor Terry is the Hall Render Professor of Law at Indiana University Robert H. McKinney School of Law, where he serves as the Executive Director of the Hall Center for Law and Health. He serves on the Scientific Leadership team for the University’s $50 million “Responding to the Addictions Crisis Grand Challenge” initiative and is engaged in research identifying barriers to effective opioids interventions to combat this public health crisis.
